gui_ge
50ug
biao_da_su_zhu
Human Cells
biao_qian
8A5
xing_tai
Supplied as a 0.2 μm filtered solution of PBS, pH 7.4
huo_xing
Anti-2019-nCoV S-hIgG1 Antibody (8A5)(Cat#DA034) can block Human ACE-2-Avi-His (Cat#CY51) and 2019-nCoV S Protein RBD-SD1-His(Cat#DRA42) interaction, the IC50 for this effect is 0.165 ug/ml.
chu_cun_fang_fa
24 months from manufacturing at <-20 °C; 1 month, 2 to 8 °C under sterile conditions.
yun_shu_tiao_jian
The product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below.
bei_jing_shuo_ming
The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
⚠️ 本产品仅供科研使用,不用于临床诊断。